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Background: The innate immune response in the brain is initiated by pathogen-associated molecular patterns
(PAMPS) or danger-associated molecular patterns (DAMPS) produced in response to central nervous system (CNS)
infection or injury. These molecules activate members of the Toll-like receptor (TLR) family, of which TLR4 is the
receptor for bacterial lipopolysaccharide (LPS). Although neurons have been reported to express TLR4, the function
of TLR4 activation in neurons remains unknown.
Methods: TLR4 mRNA expression in primary mouse glial and neuronal cultures was assessed by RT-PCR. Mouse
mixed glial, neuronal or endothelial cell cultures were treated with LPS in the absence or the presence of a TLR4
specific antagonist (VIPER) or a specific JNK inhibitor (SP600125). Expression of inflammatory mediators was assayed
by cytometric bead array (CBA) and ELISA. Activation of extracellular-signal regulated kinase 1/2 (ERK1/2), p38,
c-Jun-N-terminal kinase (JNK) and c-Jun was assessed by Western blot. The effect of conditioned media of
untreated- versus LPS-treated glial or neuronal cultures on endothelial activation was assessed by neutrophil
transmigration assay, and immunocytochemistry and ELISA were used to measure expression of intercellular cell
adhesion molecule (ICAM-1) and vascular cell adhesion molecule (VCAM-1).
Results: LPS induces strong release of the chemokines RANTES and CXCL1 (KC), tumor necrosis factor-α (TNFα) and
IL-6 in primary mouse neuronal cultures. In contrast, LPS induced release of IL-1α, IL-1β and granulocyte-colony
stimulating factor (G-CSF) in mixed glial, but not in neuronal cultures. LPS-induced neuronal KC expression and
release were completely blocked by VIPER. In glial cultures, LPS induced activation of ERK1/2, p38 and JNK. In
contrast, in neuronal cultures, LPS activated JNK but not ERK1/2 or p38, and the specific JNK inhibitor SP600125
significantly blocked LPS-induced KC expression and release. Finally, conditioned medium of LPS-treated neuronal
cultures induced strong expression of ICAM-1 and VCAM-1 on endothelial cells, and induced infiltration of
neutrophils across the endothelial monolayer, which was inhibited by VIPER.
Conclusion: These data demonstrate for the first time that neurons can play a role as key sensors of infection to
initiate CNS inflammation.
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Tissue infection or injury triggers innate immunity,
which is the first line of defense against invading patho-
gens leading to initiation of inflammation, clearance of
pathogen and tissue repair. This response is initiated via
recognition of pathogen-associated molecular patterns
(PAMPS) by pathogen recognition receptors (PRRs) such
as the Toll-like receptors (TLRs) (see [1] for review).
This family of receptors has been characterized for their
homology with the Toll receptor of Drosophila that is
involved in dorso-ventral patterning during fly develop-
ment. The innate immune response is also initiated
upon tissue injury in the absence of infection, a mechan-
ism known as sterile inflammation, during which injured
cells release endogenous molecule messengers, called
danger-associated molecular patterns (DAMPS) that can
also activate TLRs [2,3]. To date, 13 TLR isoforms have
been identified in mammals, each of which recognizes
specific PAMPS or DAMPS [4]. Specifically, TLR4 is the
receptor for bacterial lipopolysaccharide (LPS), and its
activation by LPS leads to the activation of mitogen-
activated protein kinases (MAPKs), extracellular-signal
regulated kinase 1/2 (ERK1/2), p38 and c-Jun-N-terminal
kinase (JNK) in circulating and tissue-specific macrophages
[5]. Activation of TLRs leads to macrophage activation,
characterized by expression of major histocompatibility
complex (MHC) class I and II molecules, expression of
various cytokines and chemokines and initiation of adaptive
immune response and inflammation [6].
The innate immune response in the brain occurs in
response to central nervous system (CNS) infection or
injury, such as meningitis, stroke or brain trauma (see
[7] for review). It is characterized by a rapid activation
of microglia (brain-specific macrophages), activation of
the brain endothelium, expression of various pro-
inflammatory mediators (including cytokines and che-
mokines), and subsequent neutrophil infiltration into
the brain tissue [8]. TLR4 activation mediates central
inflammation in response to CNS infection and injury,
and we found recently that ischemic brain damage is
significantly reduced in TLR4 deficient mice compared
to wild type mice [9]. Although the role of TLR4 acti-
vation in microglia has been investigated extensively,
there has been debate regarding TLR4 expression by
other brain cells. Early studies found that TLR4 is
expressed primarily by microglia but not by astrocytes
or neurons [10,11]. In contrast, other studies found
that brain cells, and in particular neurons, can express
TLR4 [12-14], and TLR signaling (including TLR4) in
neuronal cells regulates neural precursor cell prolifera-
tion, axonal growth, neuronal plasticity and adult
neurogenesis (see [15] for review). However, the role
of neuronal TLR4 in CNS innate immunity remains
completely unknown.Here we demonstrate for the first time that neuronal
TLR4 activation by LPS in vitro induces strong expres-
sion of neuronal chemokines in a JNK-dependent man-
ner, and triggers endothelial activation and subsequent
neutrophil trans-endothelial migration. These data dem-
onstrate for the first time that neuronal TLR4 activation
can play a key role in the initiation of innate immunity
during CNS infection or injury.Methods
Animals and reagents
This study used C57BL/6 mice that were housed at
21°C ± 1°C, 55%± 10% humidity and maintained in a
12 hour light–dark cycle with free access to food and
water. All animals were used according to the Animals
(Scientific Procedures) Act (UK) 1986, and were eutha-
nized according with our Project Licence (PL40/3076)
approved by the Home Office (UK). Cell culture
reagents were purchased from Invitrogen (Paisley, UK),
Sigma (Gillingham, UK), and Biowhittaker (Wokingham,
UK). Fetal bovine serum (FBS) was obtained from PAA
Laboratories (Dartmouth, UK) and plasma-derived
serum (PDS) was from First Link Ltd (Wolverhampton,
UK). Ultrapure LPS (Escherichia coli 0111:B4) was pur-
chased from Invitrogen. The specific TLR4 antagonist
VIPER and its control peptide (CP7) were provided by
Dr Andrew Bowie (Trinity College Dublin, Ireland). All
other reagents were purchased from Sigma unless stated
otherwise.Primary glial, neuronal and endothelial cell cultures
Primary mixed glial cultures were prepared from the
brains of one- to three-day-old mice as described previ-
ously [16] using (D)MEM supplemented with 10% FBS,
1 U/ml penicillin and 1 μg/ml streptomycin, and grown
in a humidified incubator at 37°C with 5% CO2, 95% air
until reaching confluency (14 to 20 days in vitro (DIV)).
Astrocytes or microglia were extracted and purified from
mixed glial cultures, and cultured in (D)MEM supple-
mented with 10% FBS, 1 U/ml penicillin and 1 μg/ml
streptomycin as previously reported [16].
Primary neuronal cell cultures were prepared from the
brains of mouse embryos at 14 to 16 days of gestation as
described previously [17]. Cells were seeded at a density
of 6 x 105 cells/ml onto poly-D-lysine (PDL)-coated tis-
sue culture plates in neurobasal medium containing 1
U/ml penicillin, 1 μg/ml streptomycin, 1% glutamine, 5%
PDS, 2% B27 without antioxidants and 20 μM 5’-fluoro-
2-deoxyuridine (FUDR) to inhibit glial cell growth. Cul-
tures were grown in a humidified incubator at 37°C with
5% CO2, 95% air until 12 DIV, and were composed of
99% neurons with less than 1% glial contamination, as
assessed by immunocytochemistry (not shown).
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prepared from the brains of 4- to 12- week-old C57BL/6
mice as previously reported [18]. Endothelial cells
were grown in medium consisting of (D)MEM-F12, 10%
PDS, 10% FBS, 100 μg/ml of endothelial cell growth
supplement (BD Biosciences, Oxford, UK), 100 μg/ml
heparin, 2 mM glutamine, 1 U/ml penicillin and 1 μg/ml
streptomycin, and were used when cultures reached
confluency (14 DIV). The purity of endothelial cultures
was close to 100%, as characterized by Zona Occludens-1
and Von-Willebrand factor immunocytochemistry (data
not shown).
Reverse transcriptase polymerase chain reaction
Total RNA was extracted using TrizolW Reagent (Invi-
trogen) according the manufacturer’s instructions, and
1 μg of total RNA was then reverse transcribed with
Moloney murine leukemia virus reverse transcriptase
(Invitrogen) for 1 hour at 37°C. PCR amplification of
2 μl of cDNA was performed using a ReadyMixTM Taq
PCR Reaction Kit (Sigma) with 10 pM of specific forward
and reverse primers for TLR4 [19] and glyceraldehyde 3-
phosphate dehydrogenase (GAPDH) as housekeeping
gene (primers sequences and amplification programs are
available upon request). The amplified cDNAs (481 bp
for TLR4 and 239 bp for GAPDH) were visualized on a
1.5% agarose gel by electrophoresis at 100 V for 60 min,
and the image was captured using an Image Quant 350
camera (GE healthcare, Cardiff, UK).
Cell treatments and sample preparation
Cultures were treated with LPS (0.1 to 100 ng/ml diluted
in PBS or dimethyl sulfoxide (DMSO)) for 15 to
120 min (for ERK1/2, p38, JNK and c-Jun activation) or
24 hours (for inflammatory mediator expression and
neutrophil transmigration experiments). To study the in-
volvement of neuronal TLR4 signaling on the expression
of the chemokine CXCL1 (KC) and neutrophil transmi-
gration, neurons were pre-incubated with TLR4 specific
antagonist (VIPER) or control peptide (CP7) diluted in
PBS, 30 min prior to treatment with LPS. The involve-
ment of the JNK signaling pathway in LPS actions in
neurons was assessed by treating cultures with DMSO
alone or with a specific JNK inhibitor (SP600125, diluted
in DMSO), 30 min prior to treatment with LPS (diluted
in DMSO).
Inflammatory mediator expression
Expression levels of inflammatory mediators including
TNFα, regulated upon activation normal T-cell expressed
and presumably secreted (RANTES, CCL5), KC, IL-6, IL-
1α, IL-1β and granulocyte colony-stimulating factor (G-
CSF), were assayed using a mouse-specific cytometricbead array (CBA) (BD Biosciences, UK) according to the
manufacturer’s instructions.
KC, intercellular cell adhesion molecule (ICAM-1) and
vascular cell adhesion molecule (VCAM-1) expression
levels were assayed using an ELISA kit (R&D Systems,
Abingdon, UK). Standards and samples (100 μl) were
assayed in duplicate. The absorbance was measured by
using a plate reader (MRX, Dynatech, Willenhall, UK)
and results were calculated from the standard curve.
The minimum detection limit was 13 pg/ml for KC
ELISA and 16 pg/ml for ICAM-1 and VCAM-1 ELISAs.
Western blot analysis
Activation of ERK1/2, JNK, p38 and c-Jun was assessed
by Western blot analysis using total and phosphorylated
specific antibodies (New England Biolabs, Hitchin, UK)
diluted 1:1000 in Tween-PBS containing 1% BSA, fol-
lowed by incubation with a secondary horseradish per-
oxidase (HRP)-conjugated anti-rabbit antibody (DAKO,
Glostrup, Denmark) diluted 1:500 in 10% non fat dry
milk in Tween-PBS, as previously described [16]. Detec-
tion of the secondary antibody was done by exposing the
membrane to an Image Quant 350 camera. Images (for
ERK1/2, p38 and JNK) were analyzed semi-quantitatively
by Image Quant TL 7.0 image analysis software (GE
healthcare, UK), and values were expressed as fold in-
crease compared to basal MAPK activity detected in un-
treated cultures.
Bone marrow-derived neutrophil isolation
Freshly isolated neutrophils were obtained from male
C57BL/6 mice euthanized by CO2 inhalation. Bone mar-
rows were flushed from femurs and tibias with 1 to 2 ml
of buffer A (1 mM ethylenediaminetetraacetic acid
(EDTA), 0.1% BSA in PBS) using a 25 G needle. Tissues
were homogenized through a 19 G needle and centri-
fuged at 400 g for 10 min. Cells were resuspended in
3 ml of 0.2% NaCl for 30 to 45 sec in order to lyse red
blood cells, and osmolarity was restored by the addition
of 7 ml 1.2% NaCl. The suspension was passed through
a 30 μm cell strainer, and cells were resuspended in buf-
fer A. Cells were then incubated with anti-Ly6G-biotin
antibody and anti-biotin microbeads (Miltenyi Biotech,
Bisley, UK) for 10 min at 4°C, and neutrophils were
immuno-magnetically separated by passing the cell sus-
pension through an LS column and magnet (Miltenyi).
The column was removed from the magnet and the cells
were eluted in buffer A.
Neutrophil trans-endothelial migration assay
Endothelial cells were cultured and grown to confluency
on Transwell inserts until DIV14, as stated above. Neu-
trophils (2 x 105 cells) were added to the luminal (top)
compartment of Transwells. Endothelial cultures were
Figure 1 Expression of TLR4 mRNA in neuronal and glial cell
cultures. Neuronal, mixed glial, microglial and astrocytic primary
cultures were analyzed by RT-PCR for expression of TLR4 and
GAPDH mRNAs. cDNA amplification was visualized by agarose gel
electrophoresis. Images shown are representative of three
experiments carried out on separate cultures. GAPDH,
glyceraldehyde 3-phosphate dehydrogenase; TLR4, Toll-like
receptor 4.
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diluted in fresh neuronal or glial medium) or with con-
ditioned medium from LPS (10 ng/ml)-treated neurons
or glia (collected directly 24 hours after LPS treatment
without washing), in the absence or the presence of
VIPER (2 μM) or CP7 (2 μM), added to the abluminal
(bottom) compartment of Transwells. After 24 hours,
the abluminal (transmigrated) fraction of neutrophils
was collected and centrifuged at 800 g for 10 min, and
neutrophil number was counted using a hemocytometer.
Neutrophil transmigration was expressed as a fold in-
crease compared to migration observed under control
conditions.
Immunocytochemistry
Expression of ICAM-1 and VCAM-1 in endothelial cul-
tures was visualized by immunocytochemistry using spe-
cific anti-mouse ICAM-1 or VCAM-1 primary antibodies
(R&D Systems), followed by Alexa fluor 594-conjugated
donkey-anti goat antibody (Invitrogen). Cultures were
then washed extensively in PBS and mounted on micro-
scope slides using 4',6-diamidino-2-phenylindole (DAPI)-
containing Vectashield mounting medium. Images were
acquired using a wide-field fluorescent microscope (Leica)
and processed using the Image J software.
Statistical analysis
Data were collected from a set of 3 to 5 independent
experiments, analyzed with GraphPad Prism 5.0, and
expressed as mean± SD. Comparisons between groups
of treatments were carried out using one-way analysis of
variance (ANOVA) followed by Tukey’s multiple com-
parison post-hoc test. Data were considered statistically
significant when P <0.05.
Results
TLR4 mRNA is expressed in glial and neuronal cells
TLR4 mRNA was expressed in mixed glial, microglial
and (albeit at much lower levels), in astrocytic cultures
(Figure 1), which confirmed previous studies showing
that TLR4 expression is predominant in microglial cells
[10,11]. TLR4 mRNA expression was also detected in
neuronal cultures (at levels similar to those of micro-
glia), which confirmed published studies demonstrating
that TLR4 is also constitutively expressed in neuronal
cells [15].
LPS induces expression and release of chemokines
RANTES and KC, and cytokines TNFα and IL-6 in
neuronal cultures
The role of neuronal TLR4 and LPS actions in neuronal
cells remains unknown. We first carried out a CBA ana-
lysis on the conditioned media from LPS-treated glial or
neuronal cultures to assess expression levels of keyinflammatory mediators. In mixed glial cultures, LPS
induced strong release of chemokines RANTES (63 ± 5
fold) and KC (135 ± 18 fold), cytokines TNFα (529 ± 43
fold), IL-6 (2097 ± 61 fold), IL-1α (5 ± 1 fold), IL-1β
(16 ± 8 fold) and G-CSF (437 ± 85 fold) (Table 1). In
neuronal cultures, LPS failed to induce IL-1α or IL-1β
release, and induced a much lower release of TNFα
(4 ± 1 fold), IL-6 (10 ± 2 fold) and G-CSF (2 ± 0.1 fold)
than in glial cultures. Importantly, LPS-induced RANTES
release from neurons was high (20 ± 2 fold), and the in-
crease in KC release in response to LPS was much greater
in neuronal cultures (220± 36 fold) than in glial cultures
(135± 18 fold) (Table 1). LPS-induced KC expression and
release in neurons occurred in a concentration-dependent
manner, with maximum KC expression obtained in re-
sponse to 10 ng/ml LPS, while maximum KC release was
obtained in response to 5, 10 and 100 ng/ml LPS
(Figure 2a). Therefore, 10 ng/ml LPS was the concentra-
tion chosen for all subsequent experiments.
In order to confirm that LPS-induced KC expression
and release was mediated by the action of LPS on its re-
ceptor (namely TLR4), we tested the effect of a specific
TLR4 antagonist VIPER and its control peptide (CP7)
on KC expression and release in neuronal cultures.
VIPER added at 2 μM (optimum concentration deter-
mined in concentration-dependent experiments, not
shown), 30 min prior to LPS treatment, completely abol-
ished LPS-induced KC expression and release
(Figure 2b), while VIPER alone had no effect (not
shown). In contrast, the control peptide CP7 (2 μM)
added prior to LPS treatment had no effect on LPS-
induced KC expression and release (Figure 2b). VIPER
or CP7 (added at 2 μM) had no effect on neuronal cell
death or viability, as assessed by lactate dehydrogenase
(LDH) release or methylthiazol-tetrazolium (MMT)
assay, respectively (not shown).
Table 1 Effect of LPS on cytokines and chemokines expression in mixed glial and neuronal cultures
A) Mixed glial cultures
TNFα RANTES KC IL-6 IL-1α IL-1β G-CSF
Untreated 11 ± 9 122 ± 44 29 ± 10 14 ± 4 7 ± 3 6 ± 5 10 ± 12
LPS-treated 5,673± 468*** 7,805 ± 679*** 3,974 ± 547*** 28,945 ± 837*** 36.7 ± 9.4*** 98.5 ± 50.7*** 4,283 ± 832***
B) Neuronal cultures
TNFα RANTES KC IL-6 IL-1α IL-1β G-CSF
Untreated 19 ± 16 20 ± 4 2 ± 4 7 ± 2 13± 3 13 ± 4 21 ± 6
LPS-treated 85 ± 12** 414 ± 42*** 549± 89*** 70 ± 12*** 13 ± 4 14 ± 3 38 ± 3**
Mixed glial (A) and neuronal (B) primary cultures were treated with LPS (100 ng/ml) for 24 hours, and culture supernatants were assayed for various cytokines
and chemokines by CBA analysis. Data are presented as mean ± SD of three independent experiments carried out on separate cultures. **P<0.01, ***P<0.001,
LPS-treated versus untreated cultures, using one-way ANOVA and Tukey’s multiple comparison post-hoc test. ANOVA, analysis of variance; CBA, cytometric bead
array; G-CSF, colony stimulating factor; KC, CXCL1; LPS, lipopolysaccharide; RANTES, regulated upon activation normal T-cell expressed and presumably secreted;
TNFα, tumor necrosis factor-α.
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cultures is dependent on activation of the JNK pathway,
but is independent of ERK1/2 or p38
To investigate the signaling pathways involved in the
mechanism of neuronal KC expression induced by LPS,Figure 2 Effect of LPS on KC expression and release in neuronal cultu
treated with LPS (0.1 to 100 ng/ml) for 24 hours (a). Neuronal cultures wer
in the absence or the presence of the TLR4 antagonist VIPER or control pe
assayed for KC levels by ELISA. Data are presented as mean± SD of at least
*P<0.05, **P<0.01, ***P<0.001, LPS-treated versus untreated cultures, ##P<
multiple comparison post-hoc test. ANOVA, analysis of variance; KC, CXCL1we assessed activation of the MAPKs, ERK1/2, JNK and
p83 in glial and neuronal cultures. In glial cultures, LPS
induced strong activation of ERK1/2, JNK and p38 in a
time-dependent manner, with maximum activation of
p38 and JNK detected at 60 min, and ERK1/2 detected atres. Neuronal primary cultures were left untreated (UT) or were
e left untreated (UT) or were treated with LPS (10 ng/ml) for 24 hours,
ptide CP7 (2 μM) (b). Cell lysates and culture supernatants were
three independent experiments carried out on separate cultures.
0.01 LPS + VIPER versus. LPS alone, using one-way ANOVA and Tukey’s
; LPS, lipopolysaccharide; TLR4, Toll-like receptor 4.
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nificantly elevated 120 min after treatment with LPS,
JNK and ERK1/2 activity returned to basal levels at
120 min. In neuronal cultures, LPS failed to induce acti-
vation of p38 or ERK1/2, but induced significant activa-
tion of JNK, 30 min after LPS treatment (level of
activation detected was similar to that detected in glial
cultures) (Figure 3b). JNK activity returned to basal levels
60 min after LPS treatment, as opposed to glial cultures
where JNK activity remained high up to 120 min.Figure 3 Effect of LPS on activation of p38, ERK1/2 and JNK MAPKs in
cultures were left untreated (UT) or were treated with LPS (10 ng/ml) for 1
activation by Western blot analysis. Levels of phosphorylated MAPKs were
presented as fold increase compared to untreated cultures. Data are presen
out on separate cultures. *P<0.05, **P<0.01, ***P<0.001, LPS-treated versus
comparison post-hoc test. ANOVA, analysis of variance; ERK1/2, extracellula
lipopolysaccharide; MAPK, mitogen-activated protein kinase.These observations suggest that LPS induces specific
activation of the JNK signaling pathway in neuronal
cells. To determine whether JNK mediates KC synthesis
in neuronal cells, we tested the effect of a specific JNK
inhibitor (SP600125) on LPS-induced KC release in
neuronal cultures. JNK inhibition with SP600125
blocked LPS-induced c-Jun activity, which is a direct
and specific downstream target of JNK activity
(Figure 4a). As mentioned above, LPS induced signifi-
cant release of KC from neuronal cultures after 24 hoursneuronal and mixed glial cultures. Glial (a) or neuronal (b) primary
5, 30, 60 or 120 min. Cell lysates were assayed for p38, ERK1/2 and JNK
analyzed semi-quantitatively, normalized relative to total MAPKs, and
ted as mean± SD of at least three independent experiments carried
untreated cultures, using one-way ANOVA and Tukey’s multiple
r-signal regulated kinase 1/2; JNK, c-Jun-N-terminal kinase; LPS,
Figure 4 Effect of JNK inhibition on c-Jun activity and
LPS-induced KC release in neuronal cultures. Neuronal primary
cultures were left untreated (UT), were treated with vehicle (DMSO),
or were treated with LPS (10 ng/ml prepared in DMSO) for 30 min
(for c-Jun activity, levels of phosphorylated (P-c-Jun) compared to
total (T-c-Jun) c-Jun, a) or for 24 hours (for KC release, b) in the
absence or the presence of increasing concentrations of a specific
JNK inhibitor (SP600125, JNKi) added 30 min prior to treatment with
LPS. Cell lysates were assayed for c-Jun activity by Western blot
analysis. Image shown is representative of three experiments carried
out on separate cultures (a). Culture supernatants were assayed for
KC levels by ELISA (b). Data are presented as mean± SD of at least
three independent experiments carried out on separate cultures.
**P<0.01, ***P<0.001, LPS + JNKi-treated versus LPS-treated cultures,
using one-way ANOVA and Tukey’s multiple comparison post-hoc
test. ANOVA, analysis of variance; DMSO, dimethyl sulfoxide; JNK,
c-Jun-N-terminal kinase; KC, CXCL1; LPS, lipopolysaccharide.
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SP600125, added 30 min prior to LPS treatment,
strongly inhibited LPS-induced KC release in a
concentration-dependent manner, with significant inhib-
ition detected at 25 and 50 μM SP600125 (Figure 4b).
DMSO or SP600125 alone had no effect on KC release
(Figure 4b), and no effect of DMSO or SP600125 on
neuronal viability was detected (not shown).Conditioned medium of LPS-treated neuronal cultures
induces endothelial cell activation and neutrophil
trans-endothelial migration
Brain endothelium activation and neutrophil extravasa-
tion into the brain tissues are classical hallmarks of brain
inflammation in response to CNS injury and/or infec-
tion. We, therefore, investigated whether LPS actions on
neurons influence brain endothelial cells and subsequent
neutrophil transmigration. LPS added directly to endo-
thelial cultures induced significant activation of JNK and
ERK1/2 (Figure 5a). This increase in JNK and ERK1/2
activity was maximal 15 min after LPS treatment, while
activity of both MAPKs decreased at 30 and 60 min to
reach basal levels. These actions of LPS on endothelial
cells failed to induce neutrophil transmigration across
the endothelium monolayer (Figure 5b). Basal level of
neutrophil migration across the control (untreated)
endothelial monolayer was low (1.7%). In contrast, con-
ditioned medium (CM) of LPS-treated glial cultures
(LPS Glia CM) induced a 2.7-fold increase in neutro-
phil transmigration, while conditioned medium of
LPS-treated neuronal cultures (LPS Neu CM) induced
neutrophil transmigration to a much higher level (4.7-
fold) (Figure 5b). Conditioned medium of untreated
glial (C Glia CM) or neuronal (C Neu CM) cultures
had no effect. The effect of conditioned medium of
LPS-treated neuronal cultures was significantly
reduced in the presence of VIPER (added on neuronal
cultures prior to LPS treatment), compared to condi-
tioned medium of LPS-treated neuronal cultures in
the presence of the control peptide CP7 (Figure 5c).
CP7 or VIPER alone had no effect on neutrophil
trans-endothelial migration.
Conditioned medium of LPS-treated neuronal cultures
caused increased expression of the cell adhesion mole-
cules ICAM-1 and VCAM-1, compared to conditioned
medium of untreated neuronal cultures (Figure 6a and
b). This effect was blocked by VIPER, while VIPER alone
had no effect (not shown). Finally, LPS added directly to
endothelial cultures had no effect on ICAM-1 and
VCAM-1 expression (Figure 6b).
Discussion
The innate immune response is initiated by TLR family
members that are activated by PAMPS or DAMPS in re-
sponse to infection or injury. This response in the brain
is considered to be mediated by non-neuronal cells, pri-
marily by microglial cells, since these cells are the main
immune and antigen-presenting cells in the CNS [6].
These cells express high levels of TLR4 and they re-
spond rapidly to LPS in vitro and in vivo to produce a
large array of inflammatory mediators [20]. Our study is
the first to demonstrate that neuronal cells can be key
sensors of infection since these cells respond to LPS to
Figure 5 Effect of LPS and conditioned medium of LPS-treated glial or neuronal cultures on MAPKs activation in endothelial cells and
neutrophil transmigration. Endothelial primary cultures were left untreated (UT) or were treated with LPS (10 ng/ml) for 15, 30 or 60 min. Cell
lysates were assayed for JNK and ERK1/2 activation by Western blot analysis. Levels of phosphorylated MAPKs were analyzed semi-quantitatively,
normalized relative to total MAPKs, and represented as fold increase compared to untreated cultures (a). Endothelial primary cultures were left
untreated (UT), were treated with LPS, or were treated with conditioned medium of untreated glial (C Glia CM) or neuronal cultures (C Neu CM),
or conditioned medium of LPS (10 ng/ml for 24 hours)-treated glial (LPS Glia CM) or LPS (10 ng/ml for 24 hours)-treated neurons (LPS Neu CM),
and neutrophil trans-endothelial migration was assayed (b). Endothelial primary cultures were treated with conditioned medium of neuronal
cultures treated with VIPER or CP7 (2 μM) in the absence or the presence of LPS (10 ng/ml) (LPS Neu CM), and neutrophil trans-endothelial
migration was assayed (c). Data are presented as mean± SD of three independent experiments carried out on separate cultures. *P<0.05,
**P<0.01, ***P<0.001 LPS-treated versus untreated cultures, ##P<0.01 LPS + VIPER versus LPS + CP7, using one-way ANOVA and Tukey’s multiple
comparison post-hoc test. ANOVA, analysis of variance; ERK1/2, extracellular-signal regulated kinase1/2; JNK, c-Jun-N-terminal kinase; LPS,
lipopolysaccharide; MAPK, mitogen-activated protein kinase.
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thelial cell activation and neutrophil trans-endothelial
migration.
Despite early studies demonstrating that neurons do
not express TLR4 (see [20] for review), we found thatprimary cortical neurons in our conditions express TLR4
mRNA, which is in agreement with more recent studies
showing that TLR4 is expressed in the neuronal cell
lineage. Indeed, constitutive expression of TLR4 has
been detected in hippocampal neurons [21], sensory
Figure 6 (See legend on next page.)
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Figure 6 Effect of neuronal LPS signaling on endothelial adhesion molecules expression. Endothelial primary cultures were treated with
LPS (10 ng/ml), conditioned medium of untreated (C Neu CM) or LPS-treated (LPS Neu CM) neuronal cultures, in the absence or the presence of
VIPER (2 μM). Cells were imaged for ICAM-1 and VCAM-1 expression by immunocytochemistry (a). Arrows show increased cellular expression of
ICAM-1 and VCAM-1. Cell lysates were assayed for ICAM-1 expression and VCAM-1 expression (b) by ELISA. Data are presented as mean± SD of
three independent experiments carried out on separate cultures. **P<0.01, ***P<0.001, LPS-treated versus untreated cultures, #P<0.05,
###P<0.001, LPS + VIPER versus LPS alone, using one-way ANOVA and Tukey’s multiple comparison post-hoc test. ANOVA, analysis of variance;
ICAM-1, intercellular cell adhesion molecule; LPS, lipopolysaccharide; VCAM-1, vascular cell adhesion molecule.
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http://www.jneuroinflammation.com/content/9/1/230neurons [13], neural stem cells [12] and photoreceptor
cells [14]. These observations taken together with our
data suggest that neurons can, therefore, sense bacterial
infection (and possibly endogenous DAMPs), and we
demonstrated here that neurons synthesize chemokines
(that is, RANTES and KC) as well as the cytokines
TNFα and IL-6 (albeit at much lower levels) in response
to LPS. Furthermore, we found that LPS-induced KC
synthesis in neurons is dependent on TLR4 activation
since this response was blocked by a specific TLR4 an-
tagonist (VIPER). The inflammatory responses observed
in neuronal cultures may be due to residual glial con-
tamination, but TLR4 mRNA expression was high in our
neuronal cultures implying that neurons can indeed
sense and respond to LPS. Furthermore, increased KC
release in response to LPS was much higher in neuronal
cultures (220 fold) than in glial cultures (135 fold), while
LPS-induced IL-1α, IL-1β and G-CSF expression (which
is thought to be a glial specific response) was very low
or absent in neuronal cultures, and this correlated with
the very low level of glial contamination in our neuronal
cultures. LPS-induced p38 and ERK1/2 activation found
in glial cultures was not detected in neuronal cultures,
while LPS induced strong activation of JNK in glial
but also in neuronal cultures. These data strongly sug-
gest that LPS specifically induces neuronal cells to ex-
press chemokines in a JNK-dependent manner, and we
showed that LPS-induced KC release in neurons was
completely abrogated in the presence of a specific JNK
inhibitor.
Our data confirm other studies demonstrating that
neurons can respond to TLR ligands but are the first
to demonstrate that neurons can produce inflammatory
mediators including neuronal chemokine KC in a JNK-
dependent manner. A recent study found that TLR4
activation by high-mobility group box-1 (HMGB-1, a
well-known TLR4 endogenous ligand) is involved is
seizures [22], while another study found that neuronal
KC is significantly increased during epilepsy in the rat
[23]. These data highlight the relevance of neuronal KC
triggered by TLR4 signaling in CNS disorders, which
could also play a key role during infection that occurs
during stroke [24].
We have further demonstrated that LPS signaling in
neurons induces soluble mediators that can activateendothelial cells to express key cell adhesion molecules
such as ICAM-1 and VCAM-1, which correlated with
increased neutrophil trans-endothelial migration. Indeed,
conditioned medium from LPS-treated neuronal cultures
induced strong ICAM-1 or VCAM-1 expression as well
as neutrophil trans-endothelial migration, and these
responses were dependent on neuronal TLR4 activation.
LPS (added at 10 ng/ml) could directly activate endothe-
lial cells, measured by increased JNK and ERK1/2 activa-
tion, although this effect was transient with no effect on
endothelial ICAM-1 or VCAM-1 expression. Further-
more, conditioned medium from LPS-treated neuronal
cultures induced neutrophil trans-endothelial migration
(unlike LPS alone) and this effect was much higher than
that seen with conditioned medium of LPS-treated glial
cultures. We therefore demonstrate here a key mechan-
ism by which neurons sensing infection or injury could
trigger endothelial activation, recruitment of peripheral
immune cells to initiate brain innate immunity. The
likely advantage of neurons sensing infection over
microglial cells sensing infection alone could be the de-
velopment of a rapid host response via direct activation
of the peripheral autonomic and/or neuroendocrine sys-
tems, rapid activation of neurons located in the circum-
ventricular organs (CVO), as well as neurovascular
coupling regulated by neurons in response to peripheral
/ central infection. Although LPS was used in our study
to induce TLR4 activation, its relevance to brain injury
remains controversial. Indeed, other endogenous TLR4
ligands released during injury, such as HMGB1 or heat
shock protein 70 (HSP70) [25,26], could induce similar
responses to those observed here, although this remains
to be determined.
Although we demonstrated that LPS induces expres-
sion of the chemokines RANTES and KC in neurones,
the nature of neuronal mediators that trigger endothelial
activation and neutrophil trans-endothelial migration in
our experiments remains to be investigated. Because the
role of chemokines in the activation of brain endothelia
is very well documented, the role of neuronal KC (but
possibly other mediators) in the activation of endothelial
cells here is a likely mechanism, although this remains
to be confirmed. Our data demonstrate for the first time
that along with a microglial response to LPS, neurons
can also respond to LPS and be important players in the
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http://www.jneuroinflammation.com/content/9/1/230initiation of the inflammatory response to infection or
injury in the brain. These discoveries identify new tar-
gets for the therapeutic treatment of inflammatory-
mediated CNS disorders.
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